IGNE OTC
Igene Biotechnology, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -95.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$97K
-113.8% ▼
Capital Expenditures
$172K
+24.0% ▲
5Y CAGR: +11.4%
Free Cash Flow
-$269K
-156.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$193K
-141.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2003 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$1M | -$2M | -$4M | -$141K |
| Depreciation & Amort. | $84K | $16K | $12K | $108K | $151K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $1M | $942K | $2M | $7M | $2M |
| Other Non-Cash Items | $859K | $198K | $2M | -$3M | -$2M |
| Operating Cash Flow | -$174K | $100 | $1M | $706K | -$97K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$275K | -$226K | -$172K |
| Acquisitions (Net) | $0 | -$109K | -$108K | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$10K | $0 | $20K | $0 | $0 |
| Investing Cash Flow | -$10K | -$109K | -$363K | -$226K | -$172K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$250K | $0 | $57K | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3K | $11K | $0 | $0 | $0 |
| Financing Cash Flow | -$251K | $11K | $57K | $0 | $0 |
| Net Change in Cash | -$435K | -$98K | $1M | $462K | -$193K |
| Cash End of Period | $63K | $22K | $1M | $1M | $1M |
| Free Cash Flow | -$174K | $100 | $1M | $479K | -$269K |